# AMAZE™ Asthma Implementation QI Study

> **NCT04901260** · — · COMPLETED · sponsor: **AstraZeneca** · enrollment: 117 (actual)

## Conditions studied

- Asthma

## Interventions

- **DEVICE:** AMAZE™ Disease Management Platform

## Key facts

- **NCT ID:** NCT04901260
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-11-25
- **Primary completion:** 2021-06-30
- **Final completion:** 2021-06-30
- **Target enrollment:** 117 (ACTUAL)
- **Last updated:** 2022-08-01

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04901260

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04901260, "AMAZE™ Asthma Implementation QI Study". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04901260. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*